Medical Care
Global Antihormonal Cancer Therapies Market Research Report 2025
- Sep 18, 25
- ID: 507548
- Pages: 104
- Figures: 103
- Views: 11
This report aims to provide a comprehensive presentation of the global market for Antihormonal Cancer Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antihormonal Cancer Therapies.
The Antihormonal Cancer Therapies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antihormonal Cancer Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antihormonal Cancer Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Amgen
Samyang Biopharmaceuticals
Tolmar
Bluebird Bio
Bristol-Myers Squibb
Exelixis
Guardant Health
Illumina
Novartis
Merck KGaA
AbbVie
Gilead Sciences
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co.
Sanofi
Bayer
Segment by Type
Radiations
Drugs
Surgeries
Others
Segment by Application
Breast Cancer
Prostate Cancer
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antihormonal Cancer Therapies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Antihormonal Cancer Therapies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antihormonal Cancer Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antihormonal Cancer Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Amgen
Samyang Biopharmaceuticals
Tolmar
Bluebird Bio
Bristol-Myers Squibb
Exelixis
Guardant Health
Illumina
Novartis
Merck KGaA
AbbVie
Gilead Sciences
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co.
Sanofi
Bayer
Segment by Type
Radiations
Drugs
Surgeries
Others
Segment by Application
Breast Cancer
Prostate Cancer
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antihormonal Cancer Therapies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antihormonal Cancer Therapies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Radiations
1.2.3 Drugs
1.2.4 Surgeries
1.2.5 Others
1.3 Market by Application
1.3.1 Global Antihormonal Cancer Therapies Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antihormonal Cancer Therapies Market Perspective (2020-2031)
2.2 Global Antihormonal Cancer Therapies Growth Trends by Region
2.2.1 Global Antihormonal Cancer Therapies Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Antihormonal Cancer Therapies Historic Market Size by Region (2020-2025)
2.2.3 Antihormonal Cancer Therapies Forecasted Market Size by Region (2026-2031)
2.3 Antihormonal Cancer Therapies Market Dynamics
2.3.1 Antihormonal Cancer Therapies Industry Trends
2.3.2 Antihormonal Cancer Therapies Market Drivers
2.3.3 Antihormonal Cancer Therapies Market Challenges
2.3.4 Antihormonal Cancer Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antihormonal Cancer Therapies Players by Revenue
3.1.1 Global Top Antihormonal Cancer Therapies Players by Revenue (2020-2025)
3.1.2 Global Antihormonal Cancer Therapies Revenue Market Share by Players (2020-2025)
3.2 Global Antihormonal Cancer Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antihormonal Cancer Therapies Revenue
3.4 Global Antihormonal Cancer Therapies Market Concentration Ratio
3.4.1 Global Antihormonal Cancer Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antihormonal Cancer Therapies Revenue in 2024
3.5 Global Key Players of Antihormonal Cancer Therapies Head office and Area Served
3.6 Global Key Players of Antihormonal Cancer Therapies, Product and Application
3.7 Global Key Players of Antihormonal Cancer Therapies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antihormonal Cancer Therapies Breakdown Data by Type
4.1 Global Antihormonal Cancer Therapies Historic Market Size by Type (2020-2025)
4.2 Global Antihormonal Cancer Therapies Forecasted Market Size by Type (2026-2031)
5 Antihormonal Cancer Therapies Breakdown Data by Application
5.1 Global Antihormonal Cancer Therapies Historic Market Size by Application (2020-2025)
5.2 Global Antihormonal Cancer Therapies Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Antihormonal Cancer Therapies Market Size (2020-2031)
6.2 North America Antihormonal Cancer Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Antihormonal Cancer Therapies Market Size by Country (2020-2025)
6.4 North America Antihormonal Cancer Therapies Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antihormonal Cancer Therapies Market Size (2020-2031)
7.2 Europe Antihormonal Cancer Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Antihormonal Cancer Therapies Market Size by Country (2020-2025)
7.4 Europe Antihormonal Cancer Therapies Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antihormonal Cancer Therapies Market Size (2020-2031)
8.2 Asia-Pacific Antihormonal Cancer Therapies Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Antihormonal Cancer Therapies Market Size by Region (2020-2025)
8.4 Asia-Pacific Antihormonal Cancer Therapies Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antihormonal Cancer Therapies Market Size (2020-2031)
9.2 Latin America Antihormonal Cancer Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Antihormonal Cancer Therapies Market Size by Country (2020-2025)
9.4 Latin America Antihormonal Cancer Therapies Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antihormonal Cancer Therapies Market Size (2020-2031)
10.2 Middle East & Africa Antihormonal Cancer Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Antihormonal Cancer Therapies Market Size by Country (2020-2025)
10.4 Middle East & Africa Antihormonal Cancer Therapies Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Antihormonal Cancer Therapies Introduction
11.1.4 Roche Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Antihormonal Cancer Therapies Introduction
11.2.4 Amgen Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.2.5 Amgen Recent Development
11.3 Samyang Biopharmaceuticals
11.3.1 Samyang Biopharmaceuticals Company Details
11.3.2 Samyang Biopharmaceuticals Business Overview
11.3.3 Samyang Biopharmaceuticals Antihormonal Cancer Therapies Introduction
11.3.4 Samyang Biopharmaceuticals Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.3.5 Samyang Biopharmaceuticals Recent Development
11.4 Tolmar
11.4.1 Tolmar Company Details
11.4.2 Tolmar Business Overview
11.4.3 Tolmar Antihormonal Cancer Therapies Introduction
11.4.4 Tolmar Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.4.5 Tolmar Recent Development
11.5 Bluebird Bio
11.5.1 Bluebird Bio Company Details
11.5.2 Bluebird Bio Business Overview
11.5.3 Bluebird Bio Antihormonal Cancer Therapies Introduction
11.5.4 Bluebird Bio Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.5.5 Bluebird Bio Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Antihormonal Cancer Therapies Introduction
11.6.4 Bristol-Myers Squibb Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Exelixis
11.7.1 Exelixis Company Details
11.7.2 Exelixis Business Overview
11.7.3 Exelixis Antihormonal Cancer Therapies Introduction
11.7.4 Exelixis Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.7.5 Exelixis Recent Development
11.8 Guardant Health
11.8.1 Guardant Health Company Details
11.8.2 Guardant Health Business Overview
11.8.3 Guardant Health Antihormonal Cancer Therapies Introduction
11.8.4 Guardant Health Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.8.5 Guardant Health Recent Development
11.9 Illumina
11.9.1 Illumina Company Details
11.9.2 Illumina Business Overview
11.9.3 Illumina Antihormonal Cancer Therapies Introduction
11.9.4 Illumina Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.9.5 Illumina Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Antihormonal Cancer Therapies Introduction
11.10.4 Novartis Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.10.5 Novartis Recent Development
11.11 Merck KGaA
11.11.1 Merck KGaA Company Details
11.11.2 Merck KGaA Business Overview
11.11.3 Merck KGaA Antihormonal Cancer Therapies Introduction
11.11.4 Merck KGaA Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.11.5 Merck KGaA Recent Development
11.12 AbbVie
11.12.1 AbbVie Company Details
11.12.2 AbbVie Business Overview
11.12.3 AbbVie Antihormonal Cancer Therapies Introduction
11.12.4 AbbVie Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.12.5 AbbVie Recent Development
11.13 Gilead Sciences
11.13.1 Gilead Sciences Company Details
11.13.2 Gilead Sciences Business Overview
11.13.3 Gilead Sciences Antihormonal Cancer Therapies Introduction
11.13.4 Gilead Sciences Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.13.5 Gilead Sciences Recent Development
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Details
11.14.2 Johnson & Johnson Business Overview
11.14.3 Johnson & Johnson Antihormonal Cancer Therapies Introduction
11.14.4 Johnson & Johnson Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.14.5 Johnson & Johnson Recent Development
11.15 Pfizer
11.15.1 Pfizer Company Details
11.15.2 Pfizer Business Overview
11.15.3 Pfizer Antihormonal Cancer Therapies Introduction
11.15.4 Pfizer Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.15.5 Pfizer Recent Development
11.16 Takeda
11.16.1 Takeda Company Details
11.16.2 Takeda Business Overview
11.16.3 Takeda Antihormonal Cancer Therapies Introduction
11.16.4 Takeda Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.16.5 Takeda Recent Development
11.17 Eli Lilly
11.17.1 Eli Lilly Company Details
11.17.2 Eli Lilly Business Overview
11.17.3 Eli Lilly Antihormonal Cancer Therapies Introduction
11.17.4 Eli Lilly Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.17.5 Eli Lilly Recent Development
11.18 AstraZeneca
11.18.1 AstraZeneca Company Details
11.18.2 AstraZeneca Business Overview
11.18.3 AstraZeneca Antihormonal Cancer Therapies Introduction
11.18.4 AstraZeneca Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.18.5 AstraZeneca Recent Development
11.19 Astellas
11.19.1 Astellas Company Details
11.19.2 Astellas Business Overview
11.19.3 Astellas Antihormonal Cancer Therapies Introduction
11.19.4 Astellas Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.19.5 Astellas Recent Development
11.20 Merck & Co.
11.20.1 Merck & Co. Company Details
11.20.2 Merck & Co. Business Overview
11.20.3 Merck & Co. Antihormonal Cancer Therapies Introduction
11.20.4 Merck & Co. Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.20.5 Merck & Co. Recent Development
11.21 Sanofi
11.21.1 Sanofi Company Details
11.21.2 Sanofi Business Overview
11.21.3 Sanofi Antihormonal Cancer Therapies Introduction
11.21.4 Sanofi Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.21.5 Sanofi Recent Development
11.22 Bayer
11.22.1 Bayer Company Details
11.22.2 Bayer Business Overview
11.22.3 Bayer Antihormonal Cancer Therapies Introduction
11.22.4 Bayer Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.22.5 Bayer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antihormonal Cancer Therapies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Radiations
1.2.3 Drugs
1.2.4 Surgeries
1.2.5 Others
1.3 Market by Application
1.3.1 Global Antihormonal Cancer Therapies Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antihormonal Cancer Therapies Market Perspective (2020-2031)
2.2 Global Antihormonal Cancer Therapies Growth Trends by Region
2.2.1 Global Antihormonal Cancer Therapies Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Antihormonal Cancer Therapies Historic Market Size by Region (2020-2025)
2.2.3 Antihormonal Cancer Therapies Forecasted Market Size by Region (2026-2031)
2.3 Antihormonal Cancer Therapies Market Dynamics
2.3.1 Antihormonal Cancer Therapies Industry Trends
2.3.2 Antihormonal Cancer Therapies Market Drivers
2.3.3 Antihormonal Cancer Therapies Market Challenges
2.3.4 Antihormonal Cancer Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antihormonal Cancer Therapies Players by Revenue
3.1.1 Global Top Antihormonal Cancer Therapies Players by Revenue (2020-2025)
3.1.2 Global Antihormonal Cancer Therapies Revenue Market Share by Players (2020-2025)
3.2 Global Antihormonal Cancer Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antihormonal Cancer Therapies Revenue
3.4 Global Antihormonal Cancer Therapies Market Concentration Ratio
3.4.1 Global Antihormonal Cancer Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antihormonal Cancer Therapies Revenue in 2024
3.5 Global Key Players of Antihormonal Cancer Therapies Head office and Area Served
3.6 Global Key Players of Antihormonal Cancer Therapies, Product and Application
3.7 Global Key Players of Antihormonal Cancer Therapies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antihormonal Cancer Therapies Breakdown Data by Type
4.1 Global Antihormonal Cancer Therapies Historic Market Size by Type (2020-2025)
4.2 Global Antihormonal Cancer Therapies Forecasted Market Size by Type (2026-2031)
5 Antihormonal Cancer Therapies Breakdown Data by Application
5.1 Global Antihormonal Cancer Therapies Historic Market Size by Application (2020-2025)
5.2 Global Antihormonal Cancer Therapies Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Antihormonal Cancer Therapies Market Size (2020-2031)
6.2 North America Antihormonal Cancer Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Antihormonal Cancer Therapies Market Size by Country (2020-2025)
6.4 North America Antihormonal Cancer Therapies Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antihormonal Cancer Therapies Market Size (2020-2031)
7.2 Europe Antihormonal Cancer Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Antihormonal Cancer Therapies Market Size by Country (2020-2025)
7.4 Europe Antihormonal Cancer Therapies Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antihormonal Cancer Therapies Market Size (2020-2031)
8.2 Asia-Pacific Antihormonal Cancer Therapies Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Antihormonal Cancer Therapies Market Size by Region (2020-2025)
8.4 Asia-Pacific Antihormonal Cancer Therapies Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antihormonal Cancer Therapies Market Size (2020-2031)
9.2 Latin America Antihormonal Cancer Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Antihormonal Cancer Therapies Market Size by Country (2020-2025)
9.4 Latin America Antihormonal Cancer Therapies Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antihormonal Cancer Therapies Market Size (2020-2031)
10.2 Middle East & Africa Antihormonal Cancer Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Antihormonal Cancer Therapies Market Size by Country (2020-2025)
10.4 Middle East & Africa Antihormonal Cancer Therapies Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Antihormonal Cancer Therapies Introduction
11.1.4 Roche Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Antihormonal Cancer Therapies Introduction
11.2.4 Amgen Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.2.5 Amgen Recent Development
11.3 Samyang Biopharmaceuticals
11.3.1 Samyang Biopharmaceuticals Company Details
11.3.2 Samyang Biopharmaceuticals Business Overview
11.3.3 Samyang Biopharmaceuticals Antihormonal Cancer Therapies Introduction
11.3.4 Samyang Biopharmaceuticals Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.3.5 Samyang Biopharmaceuticals Recent Development
11.4 Tolmar
11.4.1 Tolmar Company Details
11.4.2 Tolmar Business Overview
11.4.3 Tolmar Antihormonal Cancer Therapies Introduction
11.4.4 Tolmar Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.4.5 Tolmar Recent Development
11.5 Bluebird Bio
11.5.1 Bluebird Bio Company Details
11.5.2 Bluebird Bio Business Overview
11.5.3 Bluebird Bio Antihormonal Cancer Therapies Introduction
11.5.4 Bluebird Bio Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.5.5 Bluebird Bio Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Antihormonal Cancer Therapies Introduction
11.6.4 Bristol-Myers Squibb Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Exelixis
11.7.1 Exelixis Company Details
11.7.2 Exelixis Business Overview
11.7.3 Exelixis Antihormonal Cancer Therapies Introduction
11.7.4 Exelixis Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.7.5 Exelixis Recent Development
11.8 Guardant Health
11.8.1 Guardant Health Company Details
11.8.2 Guardant Health Business Overview
11.8.3 Guardant Health Antihormonal Cancer Therapies Introduction
11.8.4 Guardant Health Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.8.5 Guardant Health Recent Development
11.9 Illumina
11.9.1 Illumina Company Details
11.9.2 Illumina Business Overview
11.9.3 Illumina Antihormonal Cancer Therapies Introduction
11.9.4 Illumina Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.9.5 Illumina Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Antihormonal Cancer Therapies Introduction
11.10.4 Novartis Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.10.5 Novartis Recent Development
11.11 Merck KGaA
11.11.1 Merck KGaA Company Details
11.11.2 Merck KGaA Business Overview
11.11.3 Merck KGaA Antihormonal Cancer Therapies Introduction
11.11.4 Merck KGaA Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.11.5 Merck KGaA Recent Development
11.12 AbbVie
11.12.1 AbbVie Company Details
11.12.2 AbbVie Business Overview
11.12.3 AbbVie Antihormonal Cancer Therapies Introduction
11.12.4 AbbVie Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.12.5 AbbVie Recent Development
11.13 Gilead Sciences
11.13.1 Gilead Sciences Company Details
11.13.2 Gilead Sciences Business Overview
11.13.3 Gilead Sciences Antihormonal Cancer Therapies Introduction
11.13.4 Gilead Sciences Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.13.5 Gilead Sciences Recent Development
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Details
11.14.2 Johnson & Johnson Business Overview
11.14.3 Johnson & Johnson Antihormonal Cancer Therapies Introduction
11.14.4 Johnson & Johnson Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.14.5 Johnson & Johnson Recent Development
11.15 Pfizer
11.15.1 Pfizer Company Details
11.15.2 Pfizer Business Overview
11.15.3 Pfizer Antihormonal Cancer Therapies Introduction
11.15.4 Pfizer Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.15.5 Pfizer Recent Development
11.16 Takeda
11.16.1 Takeda Company Details
11.16.2 Takeda Business Overview
11.16.3 Takeda Antihormonal Cancer Therapies Introduction
11.16.4 Takeda Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.16.5 Takeda Recent Development
11.17 Eli Lilly
11.17.1 Eli Lilly Company Details
11.17.2 Eli Lilly Business Overview
11.17.3 Eli Lilly Antihormonal Cancer Therapies Introduction
11.17.4 Eli Lilly Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.17.5 Eli Lilly Recent Development
11.18 AstraZeneca
11.18.1 AstraZeneca Company Details
11.18.2 AstraZeneca Business Overview
11.18.3 AstraZeneca Antihormonal Cancer Therapies Introduction
11.18.4 AstraZeneca Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.18.5 AstraZeneca Recent Development
11.19 Astellas
11.19.1 Astellas Company Details
11.19.2 Astellas Business Overview
11.19.3 Astellas Antihormonal Cancer Therapies Introduction
11.19.4 Astellas Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.19.5 Astellas Recent Development
11.20 Merck & Co.
11.20.1 Merck & Co. Company Details
11.20.2 Merck & Co. Business Overview
11.20.3 Merck & Co. Antihormonal Cancer Therapies Introduction
11.20.4 Merck & Co. Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.20.5 Merck & Co. Recent Development
11.21 Sanofi
11.21.1 Sanofi Company Details
11.21.2 Sanofi Business Overview
11.21.3 Sanofi Antihormonal Cancer Therapies Introduction
11.21.4 Sanofi Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.21.5 Sanofi Recent Development
11.22 Bayer
11.22.1 Bayer Company Details
11.22.2 Bayer Business Overview
11.22.3 Bayer Antihormonal Cancer Therapies Introduction
11.22.4 Bayer Revenue in Antihormonal Cancer Therapies Business (2020-2025)
11.22.5 Bayer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Antihormonal Cancer Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Radiations
Table 3. Key Players of Drugs
Table 4. Key Players of Surgeries
Table 5. Key Players of Others
Table 6. Global Antihormonal Cancer Therapies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Antihormonal Cancer Therapies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Antihormonal Cancer Therapies Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Antihormonal Cancer Therapies Market Share by Region (2020-2025)
Table 10. Global Antihormonal Cancer Therapies Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Antihormonal Cancer Therapies Market Share by Region (2026-2031)
Table 12. Antihormonal Cancer Therapies Market Trends
Table 13. Antihormonal Cancer Therapies Market Drivers
Table 14. Antihormonal Cancer Therapies Market Challenges
Table 15. Antihormonal Cancer Therapies Market Restraints
Table 16. Global Antihormonal Cancer Therapies Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Antihormonal Cancer Therapies Market Share by Players (2020-2025)
Table 18. Global Top Antihormonal Cancer Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antihormonal Cancer Therapies as of 2024)
Table 19. Ranking of Global Top Antihormonal Cancer Therapies Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Antihormonal Cancer Therapies Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Antihormonal Cancer Therapies, Headquarters and Area Served
Table 22. Global Key Players of Antihormonal Cancer Therapies, Product and Application
Table 23. Global Key Players of Antihormonal Cancer Therapies, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Antihormonal Cancer Therapies Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Antihormonal Cancer Therapies Revenue Market Share by Type (2020-2025)
Table 27. Global Antihormonal Cancer Therapies Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Antihormonal Cancer Therapies Revenue Market Share by Type (2026-2031)
Table 29. Global Antihormonal Cancer Therapies Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Antihormonal Cancer Therapies Revenue Market Share by Application (2020-2025)
Table 31. Global Antihormonal Cancer Therapies Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Antihormonal Cancer Therapies Revenue Market Share by Application (2026-2031)
Table 33. North America Antihormonal Cancer Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Antihormonal Cancer Therapies Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Antihormonal Cancer Therapies Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Antihormonal Cancer Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Antihormonal Cancer Therapies Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Antihormonal Cancer Therapies Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Antihormonal Cancer Therapies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Antihormonal Cancer Therapies Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Antihormonal Cancer Therapies Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Antihormonal Cancer Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Antihormonal Cancer Therapies Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Antihormonal Cancer Therapies Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Antihormonal Cancer Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Antihormonal Cancer Therapies Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Antihormonal Cancer Therapies Market Size by Country (2026-2031) & (US$ Million)
Table 48. Roche Company Details
Table 49. Roche Business Overview
Table 50. Roche Antihormonal Cancer Therapies Product
Table 51. Roche Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 52. Roche Recent Development
Table 53. Amgen Company Details
Table 54. Amgen Business Overview
Table 55. Amgen Antihormonal Cancer Therapies Product
Table 56. Amgen Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 57. Amgen Recent Development
Table 58. Samyang Biopharmaceuticals Company Details
Table 59. Samyang Biopharmaceuticals Business Overview
Table 60. Samyang Biopharmaceuticals Antihormonal Cancer Therapies Product
Table 61. Samyang Biopharmaceuticals Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 62. Samyang Biopharmaceuticals Recent Development
Table 63. Tolmar Company Details
Table 64. Tolmar Business Overview
Table 65. Tolmar Antihormonal Cancer Therapies Product
Table 66. Tolmar Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 67. Tolmar Recent Development
Table 68. Bluebird Bio Company Details
Table 69. Bluebird Bio Business Overview
Table 70. Bluebird Bio Antihormonal Cancer Therapies Product
Table 71. Bluebird Bio Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 72. Bluebird Bio Recent Development
Table 73. Bristol-Myers Squibb Company Details
Table 74. Bristol-Myers Squibb Business Overview
Table 75. Bristol-Myers Squibb Antihormonal Cancer Therapies Product
Table 76. Bristol-Myers Squibb Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 77. Bristol-Myers Squibb Recent Development
Table 78. Exelixis Company Details
Table 79. Exelixis Business Overview
Table 80. Exelixis Antihormonal Cancer Therapies Product
Table 81. Exelixis Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 82. Exelixis Recent Development
Table 83. Guardant Health Company Details
Table 84. Guardant Health Business Overview
Table 85. Guardant Health Antihormonal Cancer Therapies Product
Table 86. Guardant Health Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 87. Guardant Health Recent Development
Table 88. Illumina Company Details
Table 89. Illumina Business Overview
Table 90. Illumina Antihormonal Cancer Therapies Product
Table 91. Illumina Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 92. Illumina Recent Development
Table 93. Novartis Company Details
Table 94. Novartis Business Overview
Table 95. Novartis Antihormonal Cancer Therapies Product
Table 96. Novartis Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 97. Novartis Recent Development
Table 98. Merck KGaA Company Details
Table 99. Merck KGaA Business Overview
Table 100. Merck KGaA Antihormonal Cancer Therapies Product
Table 101. Merck KGaA Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 102. Merck KGaA Recent Development
Table 103. AbbVie Company Details
Table 104. AbbVie Business Overview
Table 105. AbbVie Antihormonal Cancer Therapies Product
Table 106. AbbVie Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 107. AbbVie Recent Development
Table 108. Gilead Sciences Company Details
Table 109. Gilead Sciences Business Overview
Table 110. Gilead Sciences Antihormonal Cancer Therapies Product
Table 111. Gilead Sciences Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 112. Gilead Sciences Recent Development
Table 113. Johnson & Johnson Company Details
Table 114. Johnson & Johnson Business Overview
Table 115. Johnson & Johnson Antihormonal Cancer Therapies Product
Table 116. Johnson & Johnson Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 117. Johnson & Johnson Recent Development
Table 118. Pfizer Company Details
Table 119. Pfizer Business Overview
Table 120. Pfizer Antihormonal Cancer Therapies Product
Table 121. Pfizer Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 122. Pfizer Recent Development
Table 123. Takeda Company Details
Table 124. Takeda Business Overview
Table 125. Takeda Antihormonal Cancer Therapies Product
Table 126. Takeda Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 127. Takeda Recent Development
Table 128. Eli Lilly Company Details
Table 129. Eli Lilly Business Overview
Table 130. Eli Lilly Antihormonal Cancer Therapies Product
Table 131. Eli Lilly Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 132. Eli Lilly Recent Development
Table 133. AstraZeneca Company Details
Table 134. AstraZeneca Business Overview
Table 135. AstraZeneca Antihormonal Cancer Therapies Product
Table 136. AstraZeneca Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 137. AstraZeneca Recent Development
Table 138. Astellas Company Details
Table 139. Astellas Business Overview
Table 140. Astellas Antihormonal Cancer Therapies Product
Table 141. Astellas Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 142. Astellas Recent Development
Table 143. Merck & Co. Company Details
Table 144. Merck & Co. Business Overview
Table 145. Merck & Co. Antihormonal Cancer Therapies Product
Table 146. Merck & Co. Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 147. Merck & Co. Recent Development
Table 148. Sanofi Company Details
Table 149. Sanofi Business Overview
Table 150. Sanofi Antihormonal Cancer Therapies Product
Table 151. Sanofi Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 152. Sanofi Recent Development
Table 153. Bayer Company Details
Table 154. Bayer Business Overview
Table 155. Bayer Antihormonal Cancer Therapies Product
Table 156. Bayer Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 157. Bayer Recent Development
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Antihormonal Cancer Therapies Picture
Figure 2. Global Antihormonal Cancer Therapies Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Antihormonal Cancer Therapies Market Share by Type: 2024 VS 2031
Figure 4. Radiations Features
Figure 5. Drugs Features
Figure 6. Surgeries Features
Figure 7. Others Features
Figure 8. Global Antihormonal Cancer Therapies Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Antihormonal Cancer Therapies Market Share by Application: 2024 VS 2031
Figure 10. Breast Cancer Case Studies
Figure 11. Prostate Cancer Case Studies
Figure 12. Other Case Studies
Figure 13. Antihormonal Cancer Therapies Report Years Considered
Figure 14. Global Antihormonal Cancer Therapies Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Antihormonal Cancer Therapies Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Antihormonal Cancer Therapies Market Share by Region: 2024 VS 2031
Figure 17. Global Antihormonal Cancer Therapies Market Share by Players in 2024
Figure 18. Global Top Antihormonal Cancer Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antihormonal Cancer Therapies as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Antihormonal Cancer Therapies Revenue in 2024
Figure 20. North America Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Antihormonal Cancer Therapies Market Share by Country (2020-2031)
Figure 22. United States Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Antihormonal Cancer Therapies Market Share by Country (2020-2031)
Figure 26. Germany Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Antihormonal Cancer Therapies Market Share by Region (2020-2031)
Figure 34. China Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Antihormonal Cancer Therapies Market Share by Country (2020-2031)
Figure 42. Mexico Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Antihormonal Cancer Therapies Market Share by Country (2020-2031)
Figure 46. Turkey Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Roche Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 50. Amgen Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 51. Samyang Biopharmaceuticals Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 52. Tolmar Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 53. Bluebird Bio Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 55. Exelixis Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 56. Guardant Health Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 57. Illumina Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 58. Novartis Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 59. Merck KGaA Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 60. AbbVie Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 61. Gilead Sciences Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 62. Johnson & Johnson Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 63. Pfizer Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 64. Takeda Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 65. Eli Lilly Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 66. AstraZeneca Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 67. Astellas Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 68. Merck & Co. Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 69. Sanofi Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 70. Bayer Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Table 1. Global Antihormonal Cancer Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Radiations
Table 3. Key Players of Drugs
Table 4. Key Players of Surgeries
Table 5. Key Players of Others
Table 6. Global Antihormonal Cancer Therapies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Antihormonal Cancer Therapies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Antihormonal Cancer Therapies Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Antihormonal Cancer Therapies Market Share by Region (2020-2025)
Table 10. Global Antihormonal Cancer Therapies Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Antihormonal Cancer Therapies Market Share by Region (2026-2031)
Table 12. Antihormonal Cancer Therapies Market Trends
Table 13. Antihormonal Cancer Therapies Market Drivers
Table 14. Antihormonal Cancer Therapies Market Challenges
Table 15. Antihormonal Cancer Therapies Market Restraints
Table 16. Global Antihormonal Cancer Therapies Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Antihormonal Cancer Therapies Market Share by Players (2020-2025)
Table 18. Global Top Antihormonal Cancer Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antihormonal Cancer Therapies as of 2024)
Table 19. Ranking of Global Top Antihormonal Cancer Therapies Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Antihormonal Cancer Therapies Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Antihormonal Cancer Therapies, Headquarters and Area Served
Table 22. Global Key Players of Antihormonal Cancer Therapies, Product and Application
Table 23. Global Key Players of Antihormonal Cancer Therapies, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Antihormonal Cancer Therapies Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Antihormonal Cancer Therapies Revenue Market Share by Type (2020-2025)
Table 27. Global Antihormonal Cancer Therapies Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Antihormonal Cancer Therapies Revenue Market Share by Type (2026-2031)
Table 29. Global Antihormonal Cancer Therapies Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Antihormonal Cancer Therapies Revenue Market Share by Application (2020-2025)
Table 31. Global Antihormonal Cancer Therapies Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Antihormonal Cancer Therapies Revenue Market Share by Application (2026-2031)
Table 33. North America Antihormonal Cancer Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Antihormonal Cancer Therapies Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Antihormonal Cancer Therapies Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Antihormonal Cancer Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Antihormonal Cancer Therapies Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Antihormonal Cancer Therapies Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Antihormonal Cancer Therapies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Antihormonal Cancer Therapies Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Antihormonal Cancer Therapies Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Antihormonal Cancer Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Antihormonal Cancer Therapies Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Antihormonal Cancer Therapies Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Antihormonal Cancer Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Antihormonal Cancer Therapies Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Antihormonal Cancer Therapies Market Size by Country (2026-2031) & (US$ Million)
Table 48. Roche Company Details
Table 49. Roche Business Overview
Table 50. Roche Antihormonal Cancer Therapies Product
Table 51. Roche Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 52. Roche Recent Development
Table 53. Amgen Company Details
Table 54. Amgen Business Overview
Table 55. Amgen Antihormonal Cancer Therapies Product
Table 56. Amgen Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 57. Amgen Recent Development
Table 58. Samyang Biopharmaceuticals Company Details
Table 59. Samyang Biopharmaceuticals Business Overview
Table 60. Samyang Biopharmaceuticals Antihormonal Cancer Therapies Product
Table 61. Samyang Biopharmaceuticals Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 62. Samyang Biopharmaceuticals Recent Development
Table 63. Tolmar Company Details
Table 64. Tolmar Business Overview
Table 65. Tolmar Antihormonal Cancer Therapies Product
Table 66. Tolmar Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 67. Tolmar Recent Development
Table 68. Bluebird Bio Company Details
Table 69. Bluebird Bio Business Overview
Table 70. Bluebird Bio Antihormonal Cancer Therapies Product
Table 71. Bluebird Bio Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 72. Bluebird Bio Recent Development
Table 73. Bristol-Myers Squibb Company Details
Table 74. Bristol-Myers Squibb Business Overview
Table 75. Bristol-Myers Squibb Antihormonal Cancer Therapies Product
Table 76. Bristol-Myers Squibb Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 77. Bristol-Myers Squibb Recent Development
Table 78. Exelixis Company Details
Table 79. Exelixis Business Overview
Table 80. Exelixis Antihormonal Cancer Therapies Product
Table 81. Exelixis Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 82. Exelixis Recent Development
Table 83. Guardant Health Company Details
Table 84. Guardant Health Business Overview
Table 85. Guardant Health Antihormonal Cancer Therapies Product
Table 86. Guardant Health Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 87. Guardant Health Recent Development
Table 88. Illumina Company Details
Table 89. Illumina Business Overview
Table 90. Illumina Antihormonal Cancer Therapies Product
Table 91. Illumina Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 92. Illumina Recent Development
Table 93. Novartis Company Details
Table 94. Novartis Business Overview
Table 95. Novartis Antihormonal Cancer Therapies Product
Table 96. Novartis Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 97. Novartis Recent Development
Table 98. Merck KGaA Company Details
Table 99. Merck KGaA Business Overview
Table 100. Merck KGaA Antihormonal Cancer Therapies Product
Table 101. Merck KGaA Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 102. Merck KGaA Recent Development
Table 103. AbbVie Company Details
Table 104. AbbVie Business Overview
Table 105. AbbVie Antihormonal Cancer Therapies Product
Table 106. AbbVie Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 107. AbbVie Recent Development
Table 108. Gilead Sciences Company Details
Table 109. Gilead Sciences Business Overview
Table 110. Gilead Sciences Antihormonal Cancer Therapies Product
Table 111. Gilead Sciences Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 112. Gilead Sciences Recent Development
Table 113. Johnson & Johnson Company Details
Table 114. Johnson & Johnson Business Overview
Table 115. Johnson & Johnson Antihormonal Cancer Therapies Product
Table 116. Johnson & Johnson Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 117. Johnson & Johnson Recent Development
Table 118. Pfizer Company Details
Table 119. Pfizer Business Overview
Table 120. Pfizer Antihormonal Cancer Therapies Product
Table 121. Pfizer Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 122. Pfizer Recent Development
Table 123. Takeda Company Details
Table 124. Takeda Business Overview
Table 125. Takeda Antihormonal Cancer Therapies Product
Table 126. Takeda Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 127. Takeda Recent Development
Table 128. Eli Lilly Company Details
Table 129. Eli Lilly Business Overview
Table 130. Eli Lilly Antihormonal Cancer Therapies Product
Table 131. Eli Lilly Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 132. Eli Lilly Recent Development
Table 133. AstraZeneca Company Details
Table 134. AstraZeneca Business Overview
Table 135. AstraZeneca Antihormonal Cancer Therapies Product
Table 136. AstraZeneca Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 137. AstraZeneca Recent Development
Table 138. Astellas Company Details
Table 139. Astellas Business Overview
Table 140. Astellas Antihormonal Cancer Therapies Product
Table 141. Astellas Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 142. Astellas Recent Development
Table 143. Merck & Co. Company Details
Table 144. Merck & Co. Business Overview
Table 145. Merck & Co. Antihormonal Cancer Therapies Product
Table 146. Merck & Co. Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 147. Merck & Co. Recent Development
Table 148. Sanofi Company Details
Table 149. Sanofi Business Overview
Table 150. Sanofi Antihormonal Cancer Therapies Product
Table 151. Sanofi Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 152. Sanofi Recent Development
Table 153. Bayer Company Details
Table 154. Bayer Business Overview
Table 155. Bayer Antihormonal Cancer Therapies Product
Table 156. Bayer Revenue in Antihormonal Cancer Therapies Business (2020-2025) & (US$ Million)
Table 157. Bayer Recent Development
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Antihormonal Cancer Therapies Picture
Figure 2. Global Antihormonal Cancer Therapies Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Antihormonal Cancer Therapies Market Share by Type: 2024 VS 2031
Figure 4. Radiations Features
Figure 5. Drugs Features
Figure 6. Surgeries Features
Figure 7. Others Features
Figure 8. Global Antihormonal Cancer Therapies Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Antihormonal Cancer Therapies Market Share by Application: 2024 VS 2031
Figure 10. Breast Cancer Case Studies
Figure 11. Prostate Cancer Case Studies
Figure 12. Other Case Studies
Figure 13. Antihormonal Cancer Therapies Report Years Considered
Figure 14. Global Antihormonal Cancer Therapies Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Antihormonal Cancer Therapies Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Antihormonal Cancer Therapies Market Share by Region: 2024 VS 2031
Figure 17. Global Antihormonal Cancer Therapies Market Share by Players in 2024
Figure 18. Global Top Antihormonal Cancer Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antihormonal Cancer Therapies as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Antihormonal Cancer Therapies Revenue in 2024
Figure 20. North America Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Antihormonal Cancer Therapies Market Share by Country (2020-2031)
Figure 22. United States Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Antihormonal Cancer Therapies Market Share by Country (2020-2031)
Figure 26. Germany Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Antihormonal Cancer Therapies Market Share by Region (2020-2031)
Figure 34. China Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Antihormonal Cancer Therapies Market Share by Country (2020-2031)
Figure 42. Mexico Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Antihormonal Cancer Therapies Market Share by Country (2020-2031)
Figure 46. Turkey Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Antihormonal Cancer Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Roche Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 50. Amgen Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 51. Samyang Biopharmaceuticals Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 52. Tolmar Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 53. Bluebird Bio Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 55. Exelixis Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 56. Guardant Health Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 57. Illumina Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 58. Novartis Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 59. Merck KGaA Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 60. AbbVie Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 61. Gilead Sciences Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 62. Johnson & Johnson Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 63. Pfizer Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 64. Takeda Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 65. Eli Lilly Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 66. AstraZeneca Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 67. Astellas Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 68. Merck & Co. Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 69. Sanofi Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 70. Bayer Revenue Growth Rate in Antihormonal Cancer Therapies Business (2020-2025)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global UV Delayed Curing Adhesives Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Die-Casting Die Steel Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232